Does ginsenoside Rg1 promote intervertebral disc repair? An experimental study insights into ferroptosis mechanism

Nov 6, 2025Journal of translational medicine

Does Ginsenoside Rg1 Help Repair Spinal Discs? Experimental Study on Cell Death Mechanism

AI simplified

Abstract

Significant was observed in the NP tissue of IVDD patients, particularly in those with higher imaging grades.

  • Ginsenoside Rg1 significantly mitigated intervertebral disc degeneration in a rat model and promoted disc repair.
  • Key targets identified for ginsenoside Rg1's treatment of IVDD include NRF2, glutathione peroxidase 4 (GPX4), solute carrier family 7a member 11 (SLC7A11), and ferritin light chain 1 (FTL1).
  • Ginsenoside Rg1 reduced levels of reactive oxygen species (ROS) and malondialdehyde (MDA), while increasing the expression of protective proteins like glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD).
  • The NRF2/GPX4 pathway was confirmed as a key mechanism through which ginsenoside Rg1 exerts its effects on IVDD.
  • Treatment with an NRF2 inhibitor reversed the protective effects of ginsenoside Rg1 in nucleus pulposus cells.

AI simplified

Key numbers

50%
Increase in Disc Height Index
Compared to the control group, the group showed over 70% decrease in disc height.
107
Targets Identified
Network pharmacology analysis revealed these targets related to and .

Key figures

Fig. 1
markers and tissue changes in degenerated human (NP) tissue
Highlights reduced ferroptosis-related gene and protein expression in more severely degenerated NP tissue
12967_2025_7047_Fig1_HTML
  • Panel A
    Schematic of sampling degenerated NP tissue from human intervertebral discs
  • Panel B
    MRI images of human lumbar spine showing intervertebral disc degeneration graded III, IV, and V with red boxes highlighting degenerated NP regions
  • Panel C
    Histopathology () of degenerated NP tissue at grades III, IV, and V with zoomed-in views showing tissue structure; grade V appears visibly more disrupted
  • Panel D
    Bar graphs of mRNA expression levels of ferroptosis-related genes , , and in NP tissue across grades III, IV, and V showing statistically significant decreases with higher grades
  • Panel E
    Western blot images showing protein expression of GPX4, FTL1, SLC7A11, and GAPDH in NP tissue from grades III, IV, and V
  • Panel F
    Quantification of protein expression levels from Panel E showing significant reductions of GPX4, FTL1, and SLC7A11 with increasing degeneration grade
Fig. 2
Control vs vs Rg1 treatment: biochemical markers, imaging, histology, and protein expression in rat intervertebral discs
Highlights improved biochemical balance, disc structure, and protein expression with Rg1 treatment versus IVDD damage
12967_2025_7047_Fig2_HTML
  • Panel A
    Diagram of the rat experimental timeline including IVDD induction, treatments, and assessments
  • Panels B–D
    Levels of (oxidative stress marker), (antioxidant enzyme), and (glutathione peroxidase) measured; IVDD group shows higher MDA and lower SOD and GSH-Px compared to Control, with Rg1 treatment groups showing reversed trends
  • Panels E–H
    X-ray and MRI images of rat spines with red arrows indicating disc changes; IVDD group shows visibly altered disc structure and higher and scores, while Rg1 treatment groups appear improved
  • Panels I–J
    Histopathology with and showing tissue structure and proteoglycan content; IVDD group has disrupted disc morphology and lower staining intensity, Rg1 groups show partial restoration; histological grades quantify these changes
  • Panels K–M
    Immunohistochemical staining for and proteins in discs; IVDD group shows reduced Collagen II and increased MMP3 staining, Rg1 treatment groups show opposite trends quantified by average optical density (AOD)
Fig. 4
Control vs vs Rg1 treatment: protein levels and iron content related to in rat intervertebral discs
Highlights increased ferroptosis markers and iron accumulation in IVDD, with Rg1 treatment visibly restoring protein levels and reducing iron
12967_2025_7047_Fig4_HTML
  • Panels A–E
    Western Blot and quantification of , , , and protein levels; IVDD group shows reduced levels, Rg1 treatment groups (low and high dose) show increased protein expression compared to IVDD
  • Panel F
    Immunohistochemistry images of NRF2 expression in tissue sections; NRF2 staining appears visibly weaker in IVDD and stronger in Rg1 treatment groups compared to control
  • Panel G
    Immunofluorescence images of GPX4 expression with DAPI nuclear stain; GPX4 fluorescence intensity is visibly lower in IVDD and higher in Rg1 groups compared to IVDD
  • Panels H, I
    staining detecting free Fe2+ levels; IVDD group shows visibly higher iron fluorescence intensity, which appears reduced in Rg1 treatment groups
Fig. 5
Control vs HO-induced degeneration vs Rg1 treatment: , oxidative stress markers, and protein levels in
Highlights reduced oxidative stress and improved protein markers in NP cells with Rg1 treatment versus HO-induced degeneration.
12967_2025_7047_Fig5_HTML
  • Panel A
    Flow cytometry measuring lipid ROS levels in NP cells; HO group (#2) shows higher lipid ROS than Control (#1), while Rg1 treatments (#3-#5) show reduced lipid ROS.
  • Panels B–D
    Quantification of oxidative stress markers: (Panel B) is increased in HO (#2) and reduced by Rg1 (#3-#5); (Panel C) and (Panel D) levels are decreased in HO (#2) and increased with Rg1 treatment (#3-#5).
  • Panels E–G
    Western blot analysis of and protein levels: Collagen II (Panel E) is reduced and MMP3 (Panel F) increased in HO (#2) compared to Control (#1); Rg1 treatments (#3-#5) partially restore Collagen II and reduce MMP3; Panel G shows representative blot images.
  • Panels H–I
    Immunofluorescence detection of Collagen II protein: HO (#2) shows visibly lower fluorescence intensity than Control (#1); Rg1 treatments (#3-#5) show increased Collagen II fluorescence intensity.
  • Panels J–K
    Immunofluorescence detection of MMP3 protein: HO (#2) shows visibly higher fluorescence intensity than Control (#1); Rg1 treatments (#3-#5) show reduced MMP3 fluorescence intensity.
1 / 4

Full Text

What this is

  • This research investigates the effects of ginsenoside Rg1 on intervertebral disc degeneration (IVDD), a condition affecting over 500 million people worldwide.
  • The study employs both human samples and a rat model to explore the therapeutic potential of ginsenoside Rg1, particularly its role in inhibiting in nucleus pulposus cells.
  • Findings suggest that ginsenoside Rg1 can mitigate IVDD by enhancing antioxidant defenses and promoting disc repair through the NRF2/GPX4 signaling pathway.

Essence

  • Ginsenoside Rg1 mitigates intervertebral disc degeneration by inhibiting in nucleus pulposus cells, primarily through the NRF2/GPX4 pathway.

Key takeaways

  • Significant was observed in nucleus pulposus tissue of IVDD patients, correlating with higher imaging grades. This highlights the critical role of in IVDD progression.
  • Ginsenoside Rg1 significantly reduced malondialdehyde levels and restored antioxidant activity in IVDD rats, demonstrating its potential to promote intervertebral disc repair.
  • Network pharmacology identified NRF2 as a key target of ginsenoside Rg1, with molecular docking showing strong binding affinities to -related proteins.

Caveats

  • The small sample size of human tissues (n=9) limits the clinical relevance of the findings. Larger cohorts are needed for validation.
  • The study's rat model may not fully replicate human IVDD, necessitating further research to confirm translational relevance.
  • While ginsenoside Rg1's effects appear NRF2-dependent, contributions from other pathways remain possible and warrant further investigation.

Definitions

  • ferroptosis: An iron-dependent form of programmed cell death characterized by lipid peroxidation and oxidative stress.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free